National Drug Manufacturers postulate in Brussels that Poland should be on the EU's critical drug production map

The European Medicines Agency (EMA) published the first version of the EU's list of critical medicines last December 12. It identified products for which continuity of supply is required, and where interruption of treatment could result in serious health damage. Two criteria were taken into account: the severity of the disease and the availability of alternative medicines.

More than 90% of the EU's list of critical medicines are essential off-patent drugs that can be manufactured in our country.

- In Poland we have factories, competence and huge development potential. We are a large country with a strategic location. We can become a produ...